524636 Stock Overview
Manufactures and sells bulk drugs and active pharmaceutical ingredients in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Oxygenta Pharmaceutical Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹73.53 |
| 52 Week High | ₹108.64 |
| 52 Week Low | ₹26.01 |
| Beta | 0.27 |
| 11 Month Change | -29.56% |
| 3 Month Change | 95.71% |
| 1 Year Change | 133.43% |
| 33 Year Change | 157.55% |
| 5 Year Change | n/a |
| Change since IPO | 3,401.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524636 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -0.9% | 1.1% | 2.0% |
| 1Y | 133.4% | 43.3% | 28.6% |
Return vs Industry: 524636 exceeded the Indian Pharmaceuticals industry which returned 43.3% over the past year.
Return vs Market: 524636 exceeded the Indian Market which returned 28.6% over the past year.
Price Volatility
| 524636 volatility | |
|---|---|
| 524636 Average Weekly Movement | 7.9% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 524636's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 524636's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 161 | Sai Vankineni | www.oxygentapharma.com |
Oxygenta Pharmaceutical Limited manufactures and sells bulk drugs and active pharmaceutical ingredients in India. The company offers pharmaceutical preparation and organic fine chemicals. The company was formerly known as S.S.
Oxygenta Pharmaceutical Limited Fundamentals Summary
| 524636 fundamental statistics | |
|---|---|
| Market cap | ₹2.72b |
| Earnings (TTM) | ₹223.00k |
| Revenue (TTM) | ₹463.28m |
Over9,999x
P/E Ratio5.9x
P/S RatioIs 524636 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524636 income statement (TTM) | |
|---|---|
| Revenue | ₹463.28m |
| Cost of Revenue | ₹414.50m |
| Gross Profit | ₹48.79m |
| Other Expenses | ₹48.56m |
| Earnings | ₹223.00k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.006 |
| Gross Margin | 10.53% |
| Net Profit Margin | 0.048% |
| Debt/Equity Ratio | -286.7% |
How did 524636 perform over the long term?
See historical performance and comparison